Concepedia

Chuenlei Parng

CP

15

Publications

1.6K

Citations

13

H-Index

1996

Active since

Affiliations

Phylonix (United States)(Current)

Pfizer (United States)

Tonix Pharmaceuticals (United States)

Chuenlei Parng is an author at Phylonix (United States) specializing in medicine, pharmacology, and immunology.

Top concepts

MedicinePharmacologyImmunologyToxicologyImmunotherapyAutoimmunityBiochemistryNeuroscienceEcotoxicologyDrug Discovery

Publications per year

1996–2021

15

Publications

15

Zebrafish: A Preclinical Model for Drug Screening

Chuenlei Parng, Wen Lin Seng, Carlos E. Semino et al. · Assay and Drug Development Technologies · 2002 · 406 citations

The Follicular versus Marginal Zone B Lymphocyte Cell Fate Decision Is Regulated by Aiolos, Btk, and CD21

Annaiah Cariappa, Mei Tang, Chuenlei Parng et al. · Immunity · 2001 · 340 citations · Full text

Autoimmune Disease, Lymphocyte Development, Immune Cell Development +7

The use of zebrafish for assessing ototoxic and otoprotective agents

Christopher Ton, Chuenlei Parng · Hearing Research · 2005 · 223 citations

Allergy, Medicine, Toxicology +3

Neurotoxicity assessment using zebrafish

Chuenlei Parng, Nicole M. Roy, Christopher Ton et al. · Journal of Pharmacological and Toxicological Methods · 2006 · 167 citations

Neurotoxicity Assessment, Neuroprotection, Neuroscience +3

In vivo zebrafish assays for toxicity testing.

Chuenlei Parng · PubMed · 2005 · 132 citations

Toxicology Testing, Cell Culture, Laboratory Animal Study +16

Rows per page

1–5 of 15